Inrig Jula's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed May 6, 2026
- Accession no.
- 0001902368-26-000006
- Filed
- May 6, 2026
- Trade date
- May 4-6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.02M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Inrig JulaCIK 0001902368 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | MOption exerciseAcquired | +20,000 | $22.40 | +$448,000 | 131,473 | Direct | |
| May 4, 2026 | Common Stock | SSaleDisposed | −20,000 | $45.00 | −$900,000 | 111,473 | Direct | |
| May 4, 2026 | Common Stock | MOption exerciseAcquired | +4,250 | $0.00 | $0 | 115,723 | Direct | |
| May 5, 2026 | Common Stock | SSaleDisposed | −2,174 | $46.65 | −$101,417.1 | 113,549 | Direct | |
| May 6, 2026 | Common Stock | SSaleDisposed | −311 | $43.95 | −$13,668.45 | 113,238 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 34,500 | Direct | |
| May 4, 2026 | Common Stock | AGrant or awardAcquired | +8,500 | $0.00 | $0 | 8,500 | Direct | |
| May 4, 2026 | Common Stock | MOption exerciseDisposed | −4,250 | $0.00 | $0 | 4,250 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.